{"symbol":"ARKG","provider":"yahoo-finance","fetchedAt":"2025-12-27T20:45:14.875Z","asOfDate":"2025-12-27","articles":[{"id":"a96d0e31-ac71-3bb6-9c53-b42b00002b47","title":"Cathie Wood drops $1.3 million on healthcare stock","url":"https://finance.yahoo.com/m/a96d0e31-ac71-3bb6-9c53-b42b00002b47/cathie-wood-drops-%241.3.html","publisher":"TheStreet","publishedAt":"2025-12-27T18:15:33.000Z","relatedTickers":["CRSP"],"mainIdea":"Cathie Wood drops $1.3 million on healthcare stock","summary":"TheStreet: Cathie Wood drops $1.3 million on healthcare stock. Cathie Wood has seldom shied away from letting everyone know where she believes the next wave of market-changing businesses will come from. Though ARK Investâ€™s daily trades spark a ton of excitement, its latest buying in CRISPR Therapeutics (CRSP) is far from being a sudden shift. The ... Related tickers mentioned: CRSP."},{"id":"2a3adfb4-93c8-3482-9f0a-96444d5261c0","title":"Cathie Wood Doubles Down on Self-Driving and Gene-Editing Stocks Ahead of 2026","url":"https://finance.yahoo.com/news/cathie-wood-bets-big-self-155654552.html","publisher":"GuruFocus.com","publishedAt":"2025-12-26T15:56:54.000Z","relatedTickers":["ARKK","ARKW","CRSP","IBTA","WRD"],"mainIdea":"Cathie Wood Doubles Down on Self-Driving and Gene-Editing Stocks Ahead of 2026","summary":"GuruFocus.com: Cathie Wood Doubles Down on Self-Driving and Gene-Editing Stocks Ahead of 2026. Cathie Wood Buys WeRide and CRISPR as ARK Trims Ibotta Related tickers mentioned: ARKK, ARKW, CRSP, IBTA, WRD."},{"id":"ad1f2fe4-62a6-3542-97ca-e77fddda0607","title":"Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here?","url":"https://finance.yahoo.com/m/ad1f2fe4-62a6-3542-97ca-e77fddda0607/cathie-wood-is-doubling-down.html","publisher":"Barchart","publishedAt":"2025-12-24T14:00:02.000Z","relatedTickers":["ARKK","RXRX"],"mainIdea":"Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here?","summary":"Barchart: Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here?. Cathie Wood is resolute on RXRX despite its slump. Should investors follow her lead into this AI-driven biotech bet now? Related tickers mentioned: ARKK, RXRX."}]}
